Insider Transactions
| Date | Name | Title | Type | Filing | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Oct 13, 2017 | Director, Chairman & CEO | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 22,160 | $14.75 | 350,161 | |
| Oct 13, 2017 | Director, Chairman & CEO | Open market or private sale of non-derivative or derivative security | Form 4 | 22,160 | $14.75 | 328,001 | |
| Oct 13, 2017 | Director, Chairman & CEO | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 22,160 | -- | 139,378 | |
| Sep 29, 2014 | Chief Financial Officer | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 22,311 | -- | 54,189 | |
| Jun 05, 2007 | Ten Percent Owner | Conversion of derivative security | Form 4 | 22,444 | -- | -- | |
| Jun 05, 2007 | Ten Percent Owner | Conversion of derivative security | Form 4 | 22,444 | -- | -- | |
| Jun 05, 2007 | Director | Conversion of derivative security | Form 4 | 22,444 | -- | -- | |
| Jan 15, 2021 | Chief Science Officer | Grant, award or other acquisition pursuant to Rule 16b-3(d) | Form 4 | 22,458 | -- | 438,076 | |
| Feb 03, 2009 | VP, Regulatory Affairs | Grant, award or other acquisition pursuant to Rule 16b-3(d) | Form 4 | 22,500 | -- | 22,500 | |
| Jun 10, 2021 | Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | Form 4 | 22,759 | -- | 22,759 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.